These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3213272)

  • 21. Monitoring of patients with rheumatoid arthritis in longterm administration of D-penicillamine.
    Dominkus M; Chlud K; Maida EM; Grisold W
    J Rheumatol; 1992 Oct; 19(10):1648-50. PubMed ID: 1464886
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibodies to histones in rheumatoid arthritis.
    Muzellec Y; Le Goff P; Jouquan J; Fauquert P; Muller S; Youinou P
    Diagn Clin Immunol; 1988; 5(6):326-31. PubMed ID: 3219782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [5-year treatment of rheumatoid polyarthritis with D-penicillamine].
    Duquesnoy B; Cocheteux P; Siame JL; Delcambre B
    Sem Hop; 1983 May; 59(21):1641-4. PubMed ID: 6310780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [3 cases of obliterating bronchiolitis during treatment of rheumatoid polyarthritis with D-penicillamine].
    Renier JC; Bontoux-Carre E; Racineux JL
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):25-6. PubMed ID: 3704508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.
    Moens HJ; Ament BJ; Feltkamp BW; van der Korst JK
    J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [D-penicillamine in the treatment of rheumatoid polyarthritis].
    Santamaria A; Barcelo P; Menchon M; Ripoll M; Ruiz de la Torre R
    Rev Esp Reum Enferm Osteoartic; 1976; 19(2):133-79. PubMed ID: 785553
    [No Abstract]   [Full Text] [Related]  

  • 28. Lichenoid lesions of the oral mucosa in rheumatoid arthritis patients treated with penicillamine.
    Blasberg B; Dorey JL; Stein HB; Chalmers A; Conklin RJ
    J Rheumatol; 1984 Jun; 11(3):348-51. PubMed ID: 6737375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The action of D-penicillamine on the distribution of T and B-lymphocytes in rheumatoid arthritis].
    Crouzet J; Fournier C; Bach JF; Camus JP
    Rev Rhum Mal Osteoartic; 1977 May; 44(5):335-7. PubMed ID: 329400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of long-term D-penicillamine therapy in chronic polyarthritis].
    Rautenstrauch H; Laschner W; Saal JG; Fritz P
    Z Rheumatol; 1986; 45(6):319-21. PubMed ID: 3103349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myasthenia gravis as a complication of D-penicillamine therapy in rheumatoid arthritis.
    Wysocka K; Fabian F; Listewnik M
    Z Rheumatol; 1981; 40(3):135-7. PubMed ID: 7282112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunologic abnormalities during treatment with penicillamine].
    Recordier AM; Roux H; Mercier P; Maestracci D; Schiano A
    Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):566-70. PubMed ID: 64126
    [No Abstract]   [Full Text] [Related]  

  • 33. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
    Weinstein A; Rothfield NF
    J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pemphigus induced by D-penicillamine in rheumatoid arthritis. Study of 5 cases and systematic study of anti-intercellular substance antibodies of the skin in the course of treatment].
    Benveniste M; Crouzet J; Homberg JC; Lessana M; Camus JP; Hewitt J
    Nouv Presse Med; 1975 Dec; 4(44):3125-8. PubMed ID: 1220709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteinuria in D-penicillamine-treated rheumatoid arthritis.
    Crawhall JC
    J Rheumatol Suppl; 1981; 7():161-3. PubMed ID: 6939879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of D-penicillamine on serum immunoglobulins in rheumatoid arthritis].
    Gambari PF; Mioni E; Ostuni A; Volante D; Punzi L; Todesco S; Ongaro G
    Boll Soc Ital Biol Sper; 1981 May; 57(10):1127-31. PubMed ID: 6794580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Our experience in the treatment of rheumatoid polyarthritis with D-penicillamine].
    Valat JP; Neveur CA; Le Chevallier PL
    Rev Rhum Mal Osteoartic; 1978 Feb; 45(2):121-7. PubMed ID: 644236
    [No Abstract]   [Full Text] [Related]  

  • 38. [Our experience with D penicillamine in the treatment of rheumatoid polyarthritis].
    D'Eshougues JR; Delcambre B; Siame JL; Barbot V; Brion M; Duquesnoy B; Alsac J; Dulieu R
    Lille Med; 1978 Apr; 23(4):259-63. PubMed ID: 651557
    [No Abstract]   [Full Text] [Related]  

  • 39. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experiences in the treatment of chronic polyarthritis using D-penicillamine (proceedings)].
    Dürrigl T; Pucar I
    Z Rheumatol; 1976; 35 Suppl 4():suppl 464-9. PubMed ID: 983407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.